BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/SBK3/Compounds

Compounds That Target SBK3

SH3 domain binding kinase family member 3 · 10 compounds in BiohacksAI corpus

SBK3 (SH3 domain binding kinase family member 3) is a biological target with 10 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into SBK3 modulation for therapeutic and biohacking applications.

View SBK3 target page →UniProt: P0C264 ↗
Most Studied Compounds for SBK3
1
Crizotinib
298+
studies
All 10 Compounds — Ranked by Evidence
1
Tozasertib
4.33
confidence
2
Ruxolitinib
4.23
confidence
3
Nintedanib
3.61
confidence
4
Tae 684
3.43
confidence
5
Fedratinib
3.40
confidence
6
Lestaurtinib
3.04
confidence
7
R 406
2.83
confidence
8
Kw 2449
2.64
confidence
9
Su 014813
2.20
confidence
10
Crizotinib
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for SBK3 (SH3 domain binding kinase family member 3). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: SBK3 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.